• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双特异性磷酸酶6可预测孕激素治疗非典型子宫内膜增生的敏感性。

Dual-specificity phosphatase 6 predicts the sensitivity of progestin therapy for atypical endometrial hyperplasia.

作者信息

Zhang Hui, Yan Lei, Bai Yun, Li Chunyan, Guo Qiufen, Wang Chong, Zhao Xingbo, Li Mingjiang

机构信息

Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, 324 Jingwu Road, Jinan, Shandong 250021, People's Republic of China.

Department of General Surgery, Shandong Rongjun General Hospital, 23 Jiefang Road, Jinan, Shandong 250013, People's Republic of China.

出版信息

Gynecol Oncol. 2015 Mar;136(3):549-53. doi: 10.1016/j.ygyno.2014.11.008. Epub 2014 Nov 14.

DOI:10.1016/j.ygyno.2014.11.008
PMID:25451692
Abstract

OBJECTIVE

We previously found that Dual-specificity phosphatase 6 (Dusp6) over-expression enhanced the growth-promoting effect of estrogen in endometrial adenocarcinoma cells. The aim of this study was to explore the correlation of Dusp6 expression with progestin sensitivity in atypical endometrial hyperplasia (AEH) and earlier endometrial carcinomas (EC).

METHODS

Using immunohistochemistry study, we analyzed the expression of Dusp6 protein in AEH.

RESULTS

We found that progestin treatment was effective in 89% of AEH and 50% of EC. Before treatment, Dusp6 expression was significantly higher in progestin-sensitive AEH groups compared with progestin-resistant groups. After treatment, Dusp6 expression was significantly upregulated in progestin-sensitive groups, but not in progestin-resistant groups. Moreover, a high-dose of Dusp6 transfection significantly enhanced progestin-induced growth-inhibition in Ishikawa cells.

CONCLUSIONS

Dusp6 could be a predicting marker for deciding the effectiveness of progestin therapy in AEH.

摘要

目的

我们之前发现双特异性磷酸酶6(Dusp6)的过表达增强了雌激素对子宫内膜腺癌细胞的促生长作用。本研究旨在探讨Dusp6表达与非典型子宫内膜增生(AEH)及早期子宫内膜癌(EC)中孕激素敏感性之间的相关性。

方法

采用免疫组织化学研究,分析Dusp6蛋白在AEH中的表达。

结果

我们发现孕激素治疗对89%的AEH和50%的EC有效。治疗前,孕激素敏感的AEH组中Dusp6表达显著高于孕激素抵抗组。治疗后,孕激素敏感组中Dusp6表达显著上调,而孕激素抵抗组中则未上调。此外,高剂量的Dusp6转染显著增强了孕激素对Ishikawa细胞的生长抑制作用。

结论

Dusp6可能是决定孕激素治疗AEH有效性的一个预测标志物。

相似文献

1
Dual-specificity phosphatase 6 predicts the sensitivity of progestin therapy for atypical endometrial hyperplasia.双特异性磷酸酶6可预测孕激素治疗非典型子宫内膜增生的敏感性。
Gynecol Oncol. 2015 Mar;136(3):549-53. doi: 10.1016/j.ygyno.2014.11.008. Epub 2014 Nov 14.
2
Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.表皮生长因子受体信号通路参与人子宫内膜癌的孕激素抵抗:在小鼠模型中。
J Obstet Gynaecol Res. 2012 Dec;38(12):1358-66. doi: 10.1111/j.1447-0756.2012.01881.x. Epub 2012 May 21.
3
Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.长期醋酸甲羟孕酮治疗增强子宫内膜癌中的表皮生长因子受体信号传导。
Gynecol Oncol. 2007 Apr;105(1):45-54. doi: 10.1016/j.ygyno.2006.12.014. Epub 2007 Jan 22.
4
[Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].[年轻女性高分化子宫内膜腺癌及重度非典型增生保守治疗的疗效分析]
Zhonghua Fu Chan Ke Za Zhi. 2006 Apr;41(4):242-5.
5
Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.细胞凋亡可能是孕激素治疗子宫内膜增生的早期事件。
Gynecol Oncol. 2000 Nov;79(2):169-76. doi: 10.1006/gyno.2000.5955.
6
Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.对有生育潜力的年轻女性早期子宫内膜癌和复杂性不典型增生进行保留生育功能的治疗。
Int J Gynecol Cancer. 2015 Jul;25(6):1010-4. doi: 10.1097/IGC.0000000000000467.
7
Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.人类子宫内膜增生(子宫内膜癌的前驱病变)中孕激素抵抗演变所涉及的机制。
Gynecol Oncol. 2003 Feb;88(2):108-17. doi: 10.1016/s0090-8258(02)00008-2.
8
Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.双特异性磷酸酶6免疫组化与非典型子宫内膜增生及早期子宫内膜癌对保守治疗的反应相关。
Int J Gynaecol Obstet. 2022 Sep;158(3):742-747. doi: 10.1002/ijgo.14050. Epub 2021 Dec 9.
9
Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.双特异性磷酸酶 6(Dusp6)是 FGF2/ERK1/2 信号的负调节剂,可增强 17β-雌二醇诱导的子宫内膜腺癌细胞的生长。
Mol Cell Endocrinol. 2013 Aug 25;376(1-2):60-9. doi: 10.1016/j.mce.2013.02.007. Epub 2013 Feb 16.
10
[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].[孕激素保留生育功能治疗早期子宫内膜癌及子宫内膜重度不典型增生患者的妊娠率及妊娠相关因素]
Zhonghua Fu Chan Ke Za Zhi. 2013 Jul;48(7):519-22.

引用本文的文献

1
Undifferentiated endometrial carcinoma diagnosed during perimenopausal hormone therapy: a case report and literature review.围绝经期激素治疗期间诊断出的未分化子宫内膜癌:一例病例报告及文献综述
Front Oncol. 2024 Nov 22;14:1440246. doi: 10.3389/fonc.2024.1440246. eCollection 2024.
2
Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes.育龄期子宫内膜癌:保留生育功能的方法及生殖结局
Cancers (Basel). 2022 Oct 22;14(21):5187. doi: 10.3390/cancers14215187.
3
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
子宫内膜样型子宫内膜癌 2 级 IA 期(FIGO)患者的保留生育力方法:定性系统评价。
Biomed Res Int. 2022 Sep 27;2022:4070368. doi: 10.1155/2022/4070368. eCollection 2022.
4
Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis.基于ATAC-Seq和RNA-Seq综合分析鉴定子宫内膜非典型增生和子宫内膜样腺癌患者孕激素不敏感的潜在预测模型
Front Genet. 2022 Aug 26;13:952083. doi: 10.3389/fgene.2022.952083. eCollection 2022.
5
Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.子宫内膜癌细胞系获得性孕激素抵抗的综合生物信息学分析。
J Transl Med. 2019 Feb 27;17(1):58. doi: 10.1186/s12967-019-1814-6.
6
Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway.双特异性磷酸酶1缺乏通过丝裂原活化蛋白激酶/细胞外信号调节激酶途径的激活诱导子宫内膜样腺癌进展。
Chin Med J (Engl). 2016 May 20;129(10):1154-60. doi: 10.4103/0366-6999.181954.